Amicus Therapeutics Inc’s filing revealed that its Director BRADLEY CAMPBELL acquired Company’s shares for reported $0.14 million on Dec 01 ’25. In the deal valued at $9.93 per share,14,587 shares were bought.
Then, Castelli Jeff sold 76,158 shares, generating $773,659 in total proceeds. Upon selling the shares at $10.16, the Chief Development Officer now owns 439,318 shares.
Before that, Clark David Michael sold 25,643 shares. Amicus Therapeutics Inc shares valued at $258,933 were divested by the Chief People Officer at a price of $10.10 per share. As a result of the transaction, Clark David Michael now holds 296,975 shares, worth roughly $2.89 million.
Needham upgraded its Amicus Therapeutics Inc [FOLD] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid July from “an Equal-weight” to “an Overweight”. Morgan Stanley also remained covering FOLD and has decreased its forecast on December 13, 2024 with a “an Equal-weight” recommendation from previously “an Overweight” rating. Jefferies started covering the stock on September 06, 2024. It rated FOLD as “a Buy”.
Price Performance Review of FOLD
On Tuesday, Amicus Therapeutics Inc [NASDAQ:FOLD] saw its stock fall -0.71% to $9.73. Over the last five days, the stock has lost -1.62%. Amicus Therapeutics Inc shares have fallen nearly -2.31% since the year began. Nevertheless, the stocks have risen 3.29% over the past one year. While a 52-week high of $10.57 was reached on 11/24/25, a 52-week low of $5.51 was recorded on 06/25/25.
Levels Of Support And Resistance For FOLD Stock
The 24-hour chart illustrates a support level at 9.52, which if violated will result in even more drops to 9.31. On the upside, there is a resistance level at 9.98. A further resistance level may holdings at 10.23.
How much short interest is there in Amicus Therapeutics Inc?
A steep rise in short interest was recorded in Amicus Therapeutics Inc stocks on 2025-11-14, dropping by -0.92 million shares to a total of 18.04 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 18.95 million shares. There was a decline of -5.08%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 30, 2024 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $18 price target.
